Paclicad 260mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Paclitaxel (260mg)
Overview Paclicad 260mg Injection
Oncaspar 260mg Injection is a chemotherapeutic agent indicated for treating breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Adhere strictly to your doctor's prescribed regimen; improper use or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue use only as directed by your physician. Common side effects include nausea, vomiting, and fatigue. Serious side effects such as edema, alopecia, weight gain, and bruising are possible. Your doctor might prescribe supportive medications to mitigate these. Report unexplained bleeding or bruising, sore throat, oral ulcers, or fever immediately. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests monitoring blood cell levels and liver function are crucial. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, including antibiotics, to your physician. Drug interactions are possible; provide a comprehensive medication list. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is essential throughout treatment to prevent conception.
Uses of Paclicad 260mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas
Major Benefits of Paclicad 260mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Paclicad 260mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Paclicad 260mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Paclicad 260mg Injection works:
Oncaspar 260mg injection is a chemotherapeutic agent that disrupts microtubule formation, a process crucial for cancer cell proliferation. This disruption inhibits cancerous growth, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Paclicad 260mg Injection is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Paclicad 260mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Paclicad 260mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Paclicad 260mg Injection might induce adverse reactions that could impair driving capabilities. While driving isn't necessarily prohibited between treatment cycles, it's important to note the injection's alcohol content; driving might be imprudent.
KidneySAFE IF PRESCRIBED
Paclicad 260mg Injection can be administered to patients with kidney conditions without altering the dosage. Consult your physician, however, if you have pre-existing kidney impairment.
LiverCAUTION
Administering Paclicad 260mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Paclicad 260mg Injection might be necessary. Physician consultation is advised. Paclicad 260mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Paclicad 260mg Injection :
NA
Facts to Know About Paclicad 260mg Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently